Plenary

Regulating Basal and Inducible TCR Signaling

Saturday, June 17
8:00 AM - 8:30 AM

Learning Objectives:

Arthur Weiss

Ephraim P. Engleman Distinguished Professor Investigator, HHMI
University of California, San Francisco

Dr. Weiss is the Ephraim P. Engleman Distinguished Professor of Rheumatology in the Department of Medicine at the University of California San Francisco, where he has been on the faculty since 1985. He served as Division Chief of Rheumatology at UCSF from 1988-2011. He has been an Investigator of the Howard Hughes Medical Institute since 1985.
Dr. Weiss is a leading researcher in the field of signal transduction in the immune system, focusing on the roles of tyrosine kinases and phosphatases in regulating lymphocyte activation. He has studied how abnormalities in tyrosine phosphorylation pathways can lead to immunologically-mediated diseases.
Dr. Weiss is a member of the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences. He is a receipient of the Distinguished Investigator Award of the ACR, Arthritis Foundation’s Lee C. Howley Prize, and the American Association of Immunologists Meritorious Career Award.
Dr. Weiss a co-founder of Nurix, Inc. and is on the Scientific Advisory/Review Boards of Five Prime Therapeutics, Genentech, Molecular Stethoscope, and Portola Pharmaceuticals.

Presentation(s):

Send Email for Arthur Weiss


Assets

Regulating Basal and Inducible TCR Signaling



Attendees who have favorited this

Send Email for Regulating Basal and Inducible TCR Signaling